Toft Group Completes Executive Search for bioMérieux (Nasdaq: BMXMF) in Durham, NC

bioMerieux

Executive search firm Toft Group has placed Dr. Steven Kolkin, Pharm.D., M.S. as Director Medical and Scientific Advisor at bioMérieux in Durham, NC. Dr. Kolkin was previously Medical Science Liaison II for Anesthesia and Critical Care at Baxter Healthcare. He holds a PharmD degree from the University of Southern California in Los Angeles, CA and an M.S. degree in Parmacoeconomics from the University of Florida in Gainesville, FL.

About bioMérieux

A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors. In 2015, revenues reached €1,965 million with 90% of sales outside of France.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.